Core Viewpoint - Hofseth BioCare ASA is conducting a Subsequent Offering to raise gross proceeds of approximately NOK 30,000,000 through the issuance of up to 16,666,666 new ordinary shares at a subscription price of NOK 1.80 per share [2]. Group 1: Offering Details - The Subsequent Offering is directed towards shareholders as of 24 October 2025, with certain exclusions for those who participated in a prior private placement and shareholders in jurisdictions where the offering is unlawful [3]. - The application period for the Subsequent Offering ended on 20 November 2025, with applications received for 1,215,560 Offer Shares [4]. - The Board has allocated all 1,215,560 Offer Shares to Eligible Shareholders, and allocation letters will be sent to subscribers shortly [5]. Group 2: Share Capital Increase - A general meeting held on 20 November 2025 authorized the Board to increase the Company's share capital by up to NOK 166,666.66, pending registration with the Norwegian Register of Business Enterprises [6]. - Completion of the Subsequent Offering is contingent upon the registration of the share capital increase, receipt of payment for all subscribed Offer Shares, and valid resolutions by the Board [7].